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1. Introduction
  Diabetes mellitus, a global public health problem, is now 
emerging as an epidemic world over. The total number of 
people with diabetes is projected to rise from 171 million 
in 2000 to 366 million in 2030[1]. The excess global mortality 
attributable to diabetes in the year 2000 was estimated 
to be 2.9 million deaths, equivalent to 5.2% of all deaths. 
In people at 35-64 years of age, 6%-27% of deaths were 
attributable to diabetes[2]. Despite tremendous advances 
in medicine during the past century, there is still no cure, 
which means that effective prevention and treatment is 
of paramount importance to prevent future increases in 
disease burden[3,4].
  The ethnobotanical information reports that about 800 
plants may possess anti-diabetic potential[5]. The World 
Health Organization Expert Committee on diabetes has 
recommended that traditional medicinal herbs be further 
investigated. India has a rich history of using various potent 
herbs and herbal components for treating diabetes. Many 
Indian plants have been investigated for their beneficial 
use in different types of diabetes and have been reported in 
numerous scientific journals[6].
  Gmelina arborea (G. arborea) is one of the important 
medicinal plants in Indian Ayurvedic system of medicine. 
Its root, fruit, bark and leaves are being used in 
medicine[7,8]. The plant is used in treatment of diabetes[9-12], 
Objective: To study the effects of aqueous extract of Gmelina arborea bark on normoglycemic 
levels and streptozotocin (STZ) induced diabetes in rats. Methods: After single administration 
of the aqueous extract, plasma glucose level was determined up to 6 h. In subacute study, the 
aqueous extract was administered for 28 d and plasma glucose level was determined weekly. The 
diabetes was induced in rats by the intraperitoneal injection of STZ at a dose of 55 mg/kg body 
weight. The diabetic animals were divided into four groups containing six in each: Group 栺 
diabetic control, Group栻and 栿 treated with the aqueous extract respectively at a dose of 250 and 
500 mg/kg body weight once daily and Group 桇 treated with glibenclamide at a dose of 0.6 mg/kg 
body weight once daily. In acute study, the aqueous extract and glibenclamide were administered 
orally to rats. Plasma glucose levels were determined at 30, 60, 120, 240 and 360 min after the 
administration of the test samples. To study subacute effects, test samples (the aqueous extract 
and glibenclamide) were administered for 28 d consecutively. The effects of each test sample on 
plasma glucose level, body weight as well as food and water intake were also monitored weekly. 
The oral glucose tolerance test and biochemical indicators were estimated on day 28. Results: 
The aqueous extract did not significantly decrease the plasma glucose level in the normoglycemic 
rats as shown by the acute and subacute assays. However, after oral administration of the aqueous 
extract, the plasma glucose level was significantly (P<0.001) decreased in the diabetic rats in 
the acute study. The long-term administration of the aqueous extract significantly (P<0.001) 
reduced plasma glucose levels of the diabetic rats. Additionally, the aqueous extract also 
reduced loss of body weight and significantly decreased food and water intake in the diabetic 
animals. Nevertheless, no effects on biochemical indicators were observed at the selected doses. 
Conclusions: The aqueous extract of Gmelina arborea bark had antihyperglycemic activity 
against STZ induced diabetes in rats, after single and subacute oral administration. Moreover, it 
did not show significant glucose lowering effect in normoglycemic rats.
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snake-bite and scorpion sting[13-15]. 
  Different phytoconstituents like flavonoids, lignans, 
glycosides and alkaloids have been found in the plant. 
Luteolin[16] and indole alkaloids[17] have been isolated 
from the leaves of G. arborea. Heartwood of the plant 
showed presence of different lignans such as arboreol, 
isoarboreol, methyl arboreol, arborone, gmelanone, 
gummadiol, and 7-oxodihydrogmelinol[18-20]. Iridoid 
glycosides have been isolated from the leaves[21]. Three 
iridoid glycosides, 6-O-(3″-O-benzoyl)-alpha-L-
rhamnopyranosylcatalpol, 6-O-(3″-O-trans-cinnamoyl)-
alpha-L-rhamnopyranosylcatalpol and 6-O-(3″-O-cis-
cinnamoyl)-alpha-L-rhamnopyranosylcatalpol, were 
isolated from the aerial parts of G. arborea[22]. The bark of 
the plant showed presence of tyrosol [2-(4-hydroxyphenyl)
ethanol]; (+)-balanophonin, an 8-5′ neolignan, gmelinol, 
phenylethanoid glycoside {(-)-p-hydroxyphenylethyl [5′′′-O-
(3,4-dimethoxycinnamoyl)-b-D-apiofuranosyl(1′′′濚6′)]-b-
D-glucopyranoside}, 2,6-dimethoxy-p-benzoquinone and 
3,4,5-trimethoxyphenol[23]. 
  Various pharmacological activities of G. arborea like 
wound-healing[24], antidiarrhoeal[25] antioxidant activity[26,27] 
and antiulcer activity[28] have been reported. The toxicity 
studies of aqueous and methanol extracts of the plant have 
been reported[29,30]. In order to establish scientific basis for 
use of the bark of the plant, the present study evaluated 
its effects on streptozotocin [STZ; 2-deoxy-2-(3-methyl-
3-nitrosourea) 1-D-glucopyranose] induced diabetes in 
experimental animals.
2. Materials and methods
2.1. Plant material
  The bark of the G. arborea was collected in the month of 
November from Jawhar (District-Thane), Maharashtra, India. 
It was identified and authenticated by P.S.N. Rao of the 
Botanical Survey of India, Pune, India. A voucher specimen 
(b-03) of the stem bark is deposited in the department for 
future reference. The plant material was air-dried at room 
temperature and ground into a fine powder. The powdered 
bark was used to prepare the aqueous extract.
2.2. Preparation and doses of aqueous extract of G. arborea 
bark
  The aqueous extract of G. arborea bark was prepared 
by cold maceration technique. Powdered bark (500 g) was 
macerated with 5 L of distilled water for 7 d, with frequent 
shaking. After 7 d, the aqueous extract was filtered and 
the marc was subjected to maceration with distilled water 
again for complete extraction. After filtration, the aqueous 
extracts were combined and concentrated with the help of 
a rotary vacuum evaporator under reduced pressure. The 
aqueous extract was dried in a vacuum dryer and stored in a 
refrigerator. The yield of the aqueous extract was found to be 
20% (w/w), with respect to the powdered bark. The aqueous 
extract is reported safe up to a dose of 5 000 mg/kg body 
weight[29]. The doses of extract for the present study were 
chosen such that they were 1/10 and 1/20 of its safe dose.
2.3. Experimental animals
  Experiments were performed in Wistar rats that were 
6-8 weeks old and weighed 170-200 g at the start of 
the study. The animals were procured from Haffkine 
Institute (Mumbai, India) and housed three per cage in an 
animal house with controlled temperature of (25依2) °C, 
relative humidity of (75依5)% and 12 h light/dark cycle for 
an acclimatization period of 7 d, before carrying out the 
experiments. Food (Amrut Feeds, Maharashtra, India) and 
water were provided to each rat ad libitum. All experimental 
protocols were approved by the Institutional Animal Ethics 
Committee, constituted as per the norms of Committee for 
the Purpose of Control and Supervision of Experiments on 
Animals, and complied with the NIH guidelines for care and 
use of experimental animals.
2.4. Acute and subacute assay in normoglycemic rats
  The freshly prepared aqueous extract of G. arborea bark 
was administered orally at doses of 250 and 500 mg/kg body 
weight. Rats in the control group were administered with an 
equal volume of distilled water. Plasma was collected from 
orbital sinuses at 1-hour time interval for up to 6 h after the 
treatment. Plasma glucose levels were determined using 
GOD-POD kit (Transasia Biomedicals Ltd., India)[31,32]. In the 
long-term study, the above test samples were administered 
orally once daily for 4 weeks. Plasma glucose levels were 
determined once every week.
2.5. Induction of diabetes 
  Diabetes was induced in the rats by the intraperitoneal 
injection of STZ at a dose of 55 mg/kg body weight (dissolved 
in 0.01 mol/L ice cold sodium citrate buffer, pH 4.4). After 
48 h post the injection, the plasma glucose levels were 
measured. Each animal with a plasma glucose level above 
250 mg/dL was considered to be diabetic[33]. 
2.6. Grouping of diabetic rats
  The animals were divided into four groups: Group 栺
diabetic control (n=6), Group 栻 and 栿 , the aqueous extract 
treated (250 and 500 mg/kg body weight once daily) (n=6) and 
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Group 桇 glibenclamide (0.6 mg/kg body weight once daily). 
Along with these groups, there was also one age matched 
control group (n=6).  
2.7. Acute assay in diabetic rats
  In acute assay, the aqueous extract of G. arborea bark and 
glibenclamide were administered orally by using an oral 
feeding needle. Plasma glucose levels were determined at 
30, 60, 120, 240 and 360 min after the administration of the 
test samples.
2.8. Subacute assay in diabetic rats
  The aqueous extract of G. arborea bark and glibenclamide 
were administered for 28 d consecutively. Plasma glucose 
levels were determined on day 7, 14, 21 and 28 after the 
administration of the test samples. The effects of each test 
sample on plasma glucose level, body weight as well as food 
and water intake were also monitored on the same days. 
The oral glucose tolerance test (OGTT) was performed on 
day 28. Different biochemical indicators like cholesterol, 
high density lipoproteins, triglycerides (TG), aspartate 
aminotransferase, alanine aminotransferase, alkaline 
phosphatase, total proteins, albumin, bilirubin, creatinine 
and blood urea nitrogen (BUN) were determined using 
diagnostic kits (Transasia Biomedicals Ltd., India) with 
autoanalyser (Erba Chem 7, Germany).
2.9. Statistical analysis
  The differences between the experimental and control 
groups were determined using the statistical software 
Sigmastat Ver. 2.03 for Windows. Significant differences 
between the experimental groups were assessed by student’s 
t test. All data are expressed as mean依SEM. P-value less 
than 0.05 was considered to be significant.
3. Results
3.1. Acute and subacute effects of the aqueous extract on 
basal plasma glucose level
  The acute effect of the aqueous extract on the basal plasma 
glucose level in the normoglycemic rats is shown in Figure 
1. The single oral administration of the aqueous extract at 
a dose of 250 or 500 mg/kg body weight did not affect the 
plasma glucose levels in the normal rats compared with 
that in the control rats which received distilled water. The 
repeated administration of the aqueous extract for 28 d also 
did not show any effect on the plasma glucose levels in the 
normoglycemic rats when compared with that in the control 
rats (Figure 2).
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Figure 1. Effect of the aqueous extract of G. arborea bark on plasma 
glucose levels in normoglycemic rats after single oral administration.  
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Figure 2. Effect of the aqueous extract of G. arborea bark on plasma 
glucose levels in normoglycemic rats after repeated administration for 
28 d.
3.2. Antidiabetic activity of the aqueous extract against 
hyperglycemia in diabetic rats
  After the acute administration of the aqueous extract 
of G. arborea (250 and 500 mg/kg body weight) as well as 
glibenclamide (0.6 mg/kg body weight), the plasma glucose 
levels were significantly reduced at 2, 4 and 6 h in the STZ 
induced diabetic rats (Table 1). The diabetic rats treated 
with the aqueous extract at a dose of 500 mg/kg body weight 
showed maximum reduction in the serum glucose level at 6 h
when compared with the diabetic control. 
  The effect of the aqueous extract on the plasma glucose 
level after 28-day administration is shown in Table 2. 
Significant reduction (P<0.05) in the plasma glucose levels 
was observed on day 7 at the selected dose levels. The 
glucose level was further reduced on day 14 and day 21 after 
the administration of the aqueous extract and glibenclamide. 
The diabetic rats treated with the aqueous extract at doses of 
250 and 500 mg/kg body weight showed maximum decreases 
in the plasma glucose levels on day 28 when compared 
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with the diabetic control. The glibenclamide group showed 
maximum reduction in the glucose level on day 28 when 
compared with the aqueous extract treated and diabetic 
control groups. 
3.3. Effect of the aqueous extract on oral glucose tolerance of 
STZ induced diabetic rats
  The OGTT was performed in the diabetic rats previously 
treated with the extract for 28 d. The plasma glucose levels 
in the diabetic control and experimental groups before and 
after the oral administration of glucose are shown in Figure 
3. The aqueous extract significantly (P<0.001) reduced the 
increased plasma glucose levels in the OGTT.
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Figure 3. Effect of the aqueous extract of G. arborea bark on oral 
glucose tolerance of streptozotocin induced diabetic rats. 
***P<0.001 compared with the diabetic control.
 3.4. Effect of the aqueous extract on body weight, food intake 
and fluid intake in STZ induced diabetic rats
  The treatment with the aqueous extract at the selected 
doses decreased loss of body weight in the STZ induced 
diabetic animals (Figure 4). The subacute treatment with the 
aqueous extract for 28 d also lowered their food consumption 
and water intake significantly when compared with that in 
the diabetic control rats (Figures 5 & 6).
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Figure 4. Effect of the aqueous extract of G. arborea bark on body 
weight of streptozotocin induced diabetic rats.  
**P<0.01; ***P<0.001 (compared with the diabetic control).
3.5. Effect of the aqueous extract on biochemical indicators in 
STZ induced diabetic rats
  The effect of the aqueous extract on different biochemical 
Table 1
Effect of the aqueous extract of G. arborea bark on plasma glucose level in streptozotocin induced diabetic rats after single administration (mg/dL).
Group
Time post the administration (min)
0 30 60 120 240 360
Normal control 110.88依3.21 111.48依2.54 108.57依1.88 109.47依2.34 112.57依1.87 111.35依2.12
Diabetic control 450.37依5.51 446.41依5.00 443.88依6.12 448.73依5.37 445.75依5.01 446.83依6.12
Diabetic+Extract (250 mg/kg)   434.72依10.07   432.15依10.02 429.12依9.14    418.38依10.26*  413.88依9.81*  410.97依9.66*
Diabetic+Extract (500 mg/kg)   433.65依10.06 431.30依9.84 427.65依9.89 416.62依9.39*   411.83依9.52**   407.98依9.87**
Diabetic+Glibenclamide   441.95依10.56   432.08依10.40    417.12依11.03*   414.37依11.30*     407.27依11.33**     399.57依11.98**
The values are expressed as mean依SEM. *P<0.05; **P<0.01 (compared with the diabetic control).
Table 2
Effect of the aqueous extract of G. arborea bark on plasma glucose level in streptozotocin induced diabetic rats after consecutive administration 
for 28 d (mg/dL).
Group
Days of the treatment (d)
0 7 14 21 28
Normal control 110.88依3.21 108.69依2.71 109.07依2.37 110.12依2.17 110.47依2.11
Diabetic control 450.37依5.51 456.78依5.12 455.82依4.71 454.38依3.64 455.13依3.91
Diabetic+Extract (250 mg/kg)   434.72依10.07  428.73依7.27*   415.05依8.50**    399.01依6.01***    392.96依4.55***
Diabetic+Extract (500 mg/kg)   433.65依10.06   423.02依11.19*      409.72依10.96***      389.18依10.29***      384.07依10.06***
Diabetic+Glibenclamide   441.95依10.56     382.18依11.69***      352.08依12.17***      313.68依12.42***      283.95依11.19***
The values are expressed as mean依SEM. *P<0.05; **P<0.01; ***P<0.001 (compared with the diabetic control).
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indicators is presented in Table 3. The STZ induced 
diabetic rats showed significantly (P<0.001) increased 
levels of cholesterol and TG when compared with the 
normal control. The levels of high density lipoproteins were 
significantly (P<0.01) decreased in the diabetic rats when 
compared with those in the normal control. The reference 
drug glibenclamide significantly decreased the elevated 
cholesterol (P<0.05) and TG levels (P<0.01) in the diabetic 
rats when compared with that in the diabetic control group. 
The diabetic rats treated with the aqueous extract did not 
show any significant decrease in the levels of cholesterol 
and TG when compared with the diabetic control.
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Figure 5. Effect of the aqueous extract of G. arborea bark on feed 
intake in streptozotocin induced diabetic rats. 
*P<0.05; **P<0.01; ***P<0.001 (compared with the diabetic control).
  The diabetic rats showed significant increases in the 
liver indicators like aspartate aminotransferase (P<0.001), 
alanine aminotransferase (P<0.05), and alkaline phosphatase 
(P<0.001). The contents of total proteins and albumin were 
significantly decreased (P<0.05) in the untreated diabetic 
rats. The aqueous extract at the selected doses did not show 
any effect on these indicators. The diabetic rats exhibited 
significant (P<0.05) increases in the BUN and creatinine 
levels, while these two indicators were not significantly 
reduced in the diabetic rats treated with the aqueous extract. 
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Figure 6. Effect of the aqueous extract of G. arborea bark on fluid 
intake in streptozotocin induced diabetic rats.  
*P<0.05; **P<0.01; ***P<0.001 (compared with the diabetic control).
4. Discussion
  The present study was designed to assess the effect of the 
aqueous extract of G. arborea bark in the normoglycemic 
rats and STZ induced diabetic rats. The acute administration 
of the extract failed to decrease the normal plasma 
glucose levels in the experimental animals. The repeated 
administration of the extract for 28 d did not significantly 
reduce the normal plasma glucose levels. The studies in the 
normoglycemic rats indicated that the aqueous extract did 
not have glucose lowering effect, i.e., hypoglycemic activity, 
Table 3
Effect of the aqueous extract of G. arborea bark on biochemical indicators in streptozotocin induced diabetic rats.
Indicator Normal control Diabetic control Diabetic+Extract 
(250 mg/kg)
Diabetic+Extract 
(500 mg/kg)
Diabetic+Glibenclamide
Cholesterol   86.38依1.83 105.78依2.78†††  102.90依1.71 101.91依3.43      91.13依2.57
**
HDL   45.33依0.97  38.96依1.51††    38.36依1.40   40.28依1.93   43.35依2.32
TG   90.55依1.79 101.93依1.57†††    99.16依2.30   98.36依1.21       84.30依1.68
***
Bilirubin     0.40依0.04 0.41依0.01      0.39依0.01     0.39依0.01      0.39依0.03
AST 177.33依3.95   238.66依11.42††† 236.83依9.38 228.66依6.27 213.00依6.66
ALT   53.81依3.32 62.33依1.74†    62.50依2.32   62.16依2.23    64.16依2.63
ALP   91.50依2.95 129.50依6.88††† 125.66依2.25 125.00依4.28 114.00依5.17
TP     5.26依0.17   4.75依0.190      5.10依0.36     5.13依0.23      4.93依0.15
Albumin     2.96依0.11 2.53依0.20      2.98依0.19     2.93依0.09     3.00依0.17
BUN   21.03依0.68   51.81依1.70†††    47.30依1.71   46.51依1.78      39.98依2.63
**
Creatinine     0.473依0.033     0.765依0.021†††      0.728依0.015     0.716依0.011         0.475依0.030
***
The values are expressed as mean依SEM. †P<0.05; ††P<0.01; †††P<0.001 (compared with the normal control). *P<0.05; **P<0.01; ***P<0.001 
(compared with the diabetic control). HDL: High density lipoproteins; TG: triglycerides; AST: Aspartate aminotransferase; ALT: Alanine 
aminotransferase; ALP: Alkaline phosphatase; TP: Total proteins; BUN: Blood urea nitrogen.
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in the normal rats. STZ is a broad spectrum antibiotic which 
is used for beta-cell necrosis and to induce diabetic state 
in experimental animals. At the intracellular level, major 
phenomenon responsible for beta-cell death is free radical 
generation and nitric oxide production[34]. The aqueous 
extract of G. arborea bark has been reported for significant 
antioxidant activity[27]. Thus, the possible mechanism 
of action of the extract may be related to its free radical 
scavenging activity and protection of beta-cells. 
  In this study, the higher dose of the extract produced the 
maximum anti-diabetic effect, which suggests that the dose 
of 500 mg/kg body weight may be the effective antidiabetic 
dose of the crude extract. However, the reference drug 
glibenclamide was better in activity when compared to the 
extract at the test doses, which may be attributed to the 
crude nature of the plant extract.
  Medicinal plants and herbal extracts containing saponins, 
glycosides and phenolics have been reported to demonstrate 
antidiabetic activities. Preliminary phytochemical 
screening has also shown that G. arborea contains all the 
above phytoconstituents. It is therefore possible that the 
phytochemicals present in the plant may be responsible for 
the observed antidiabetic activity.
  In the STZ induced diabetic rats, the increased food 
consumption and decreased body weight were observed. The 
polyphagic condition and loss of weight are due to excessive 
break-down of tissue proteins[35]. Hakim et al have stated 
that decreased body weight in diabetic rats could be due 
to dehydration and catabolism of fats and proteins[36-40]. 
Increased catabolic reactions leading to muscle wasting 
might also be the cause for the reduced weight gain in 
diabetic rats[41]. The administration of the aqueous extract 
to the diabetic rats decreased food consumption and 
increased body weight, possibly due to a better control of the 
hyperglycemic state in the diabetic rats. Decreased levels of 
plasma glucose could increase body weight in STZ-diabetic 
rats[42,43]. Induction of diabetes markedly increases feed 
and water intake in the diabetic rats. The treatment with the 
aqueous extract significantly (P<0.05) reduced the feed and 
water intake.
  The diabetic rats showed increases in lipid indexes and 
liver enzymes. The treatment with the extract did not change 
these indicators significantly when compared with that in 
the diabetic control. The STZ treatment led to significant 
(P<0.001) increase in kidney biomarkers like BUN and 
creatinine when compared with that in the normal control. 
The aqueous extract did not show any significant changes in 
these two indicators after the 28-day administration. 
  In conclusion, G. arborea shows a remarkable anti-
diabetic potential in the present study. However, 
further study is required to isolate and characterize the 
antidiabetic bioactive compounds and to establish the exact 
mechanism(s) of action.
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